Clinical research support and collaboration for nhgri protocols, task area 2: regulatory support for IND and IDE submissions
Ended Awarded Last action
- Contract number
- 75N92024F00004
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $43,590
Award facts
- Contract value 100% obligated
- $43,590.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Time and Materials
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $43,590 |
About this award
This is a $43,590 delivery order contract awarded by the National Human Genome Research Institute (NHGRI) to The Emmes Company LLC, a global clinical research organization. The contract is for clinical research support and regulatory assistance with Investigational New Drug (IND) and Investigational Device Exemption (IDE) submissions related to NHGRI protocols. This task order is part of a larger $4 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract between Emmes and NHGRI for clinical research support and collaboration. The contract has no set-aside designation and runs through June 2026. Emmes has secured numerous prime contracts and subcontracts with various NIH institutes, demonstrating its expertise in supporting complex biomedical research projects, including in areas such as infectious diseases, oncology, and rare diseases.
Quick answers
Who was awarded contract 75N92024F00004?
75N92024F00004 was awarded to The Emmes Company, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2024.
How much is contract 75N92024F00004 worth?
The government has obligated $43,590 on 75N92024F00004.
Which agency awarded contract 75N92024F00004?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92024F00004, with funding from National Human Genome Research Institute (National Institutes of Health).
Is contract 75N92024F00004 an order under another contract?
Yes. 75N92024F00004 is a delivery order under 75N92023D00009, an indefinite delivery contract.
Was contract 75N92024F00004 competed?
The extent of competition for 75N92024F00004 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award